Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

H. Lee Moffitt Cancer Center and Research Institute, Inc.

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Enhancing Cancer Survivorship With Pickleball

Not Applicable

Active, not recruiting

Conditions: Cancer

First Posted Date: 2023-09-21

Last Posted Date: 2025-05-21

Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Target Recruit Count: 28

Registration Number: NCT06048822

Locations: 🇺🇸
Moffitt Cancer Center, Tampa, Florida, United States

Tumor Infiltrating Lymphocyte Therapy for Pediatric High Risk Solid Tumors

Phase 1

Recruiting

Conditions: Lymphocytes

Interventions: Biological: Tumor Infiltrating Lymphocytes, Fludarabine, Cyclophosphamide, Interleukin-2

First Posted Date: 2023-09-21

Last Posted Date: 2025-06-08

Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Target Recruit Count: 30

Registration Number: NCT06047977

Locations: 🇺🇸
Johns Hopkins All Children's Hospital, Saint Petersburg, Florida, United States

Support Through Remote Observation and Nutrition Guidance Program (STRONG-PCS)

Not Applicable

Recruiting

Conditions: Pancreatic Cancer

First Posted Date: 2023-08-21

Last Posted Date: 2025-06-19

Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Target Recruit Count: 80

Registration Number: NCT06001268

Locations: 🇺🇸
Moffitt Cancer Center, Tampa, Florida, United States

Senior Adult Hepatobiliary Prehab Study

Not Applicable

Recruiting

Conditions: Hepatobiliary Cancer
Liver Metastases
Cholangiocarcinoma

First Posted Date: 2023-06-27

Last Posted Date: 2025-05-06

Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Target Recruit Count: 25

Registration Number: NCT05921552

Locations: 🇺🇸
Moffitt Cancer Center, Tampa, Florida, United States

Genomically Guided Radiation Dose Personalization in Locally Advanced NSCLC

Early Phase 1

Active, not recruiting

Conditions: Nonsmall Cell Lung Cancer, Stage II
Nonsmall Cell Lung Cancer Stage III
Nonsmall Cell Lung Cancer
Unresectable Non-Small Cell Lung Carcinoma

First Posted Date: 2023-05-24

Last Posted Date: 2025-06-13

Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Target Recruit Count: 3

Registration Number: NCT05873439

Locations: 🇺🇸
Moffitt Cancer Center, Tampa, Florida, United States

Outreach Core Activities

Recruiting

Conditions: Cancer Education
Spanish Language Cancer Education

First Posted Date: 2023-04-27

Last Posted Date: 2025-05-23

Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Target Recruit Count: 1200

Registration Number: NCT05832177

Locations: 🇺🇸
Moffitt Cancer Center, Tampa, Florida, United States
🇵🇷
Ponce Health Sciences University, Ponce, Puerto Rico

A First in Human Dose Escalation of Dendritic Cell Vaccine (DCV)

Phase 1

Recruiting

Conditions: Triple Negative Breast Cancer
HER2-positive Breast Cancer
Leptomeningeal Disease

Interventions: Biological: Dendritic Cell Vaccine

First Posted Date: 2023-04-12

Last Posted Date: 2025-06-12

Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Target Recruit Count: 18

Registration Number: NCT05809752

Locations: 🇺🇸
Moffitt Cancer Center, Tampa, Florida, United States
🇺🇸
Roswell Park Comprehensive Cancer Center, Buffalo, New York, United States
🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

The ENHANCE Study: Exercise and Nutrition in Head And Neck CancEr Survivors

Not Applicable

Recruiting

Conditions: Larynx Cancer
Oropharynx Cancer
Oral Cavity Cancer
Hypopharynx Cancer

First Posted Date: 2023-04-05

Last Posted Date: 2025-05-07

Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Target Recruit Count: 40

Registration Number: NCT05798780

Locations: 🇺🇸
Moffitt Cancer Center, Tampa, Florida, United States

Intravesical Adoptive Cell Therapy w/ TIL for BCG Exposed High Grade NMIBC

Phase 1

Recruiting

Conditions: Non-Invasive Bladder Urothelial Carcinoma
Urothelial Carcinoma

Interventions: Biological: Adoptive Cell Therapy with Tumor-infiltrating Lymphocytes (TIL)

First Posted Date: 2023-03-14

Last Posted Date: 2025-05-06

Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Target Recruit Count: 12

Registration Number: NCT05768347

Locations: 🇺🇸
Moffitt Cancer Center, Tampa, Florida, United States

Exercise Prehabilitation Among Older Patients With Hematological Malignancies Preparing For CAR-T Cell Immunotherapy

Not Applicable

Active, not recruiting

Conditions: Leukemia
Myeloma
Lymphoma

First Posted Date: 2023-03-10

Last Posted Date: 2025-05-07

Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Target Recruit Count: 20

Registration Number: NCT05763563

Locations: 🇺🇸
Moffitt Cancer Center, Tampa, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy